Close

ContraFect Corp. (CFRX) PT Raised to $17.50 at Chardan Capital Markets

March 16, 2021 10:36 AM EDT Send to a Friend
Chardan Capital Markets analyst Keay Nakae raised the price target on ContraFect Corp. (NASDAQ: CFRX) to $17.50 (from $15.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login